[go: up one dir, main page]

MX2007007302A - Proceso para la preparacion de clorhidrato de 1-amino-3,5-dimetiladamantano. - Google Patents

Proceso para la preparacion de clorhidrato de 1-amino-3,5-dimetiladamantano.

Info

Publication number
MX2007007302A
MX2007007302A MX2007007302A MX2007007302A MX2007007302A MX 2007007302 A MX2007007302 A MX 2007007302A MX 2007007302 A MX2007007302 A MX 2007007302A MX 2007007302 A MX2007007302 A MX 2007007302A MX 2007007302 A MX2007007302 A MX 2007007302A
Authority
MX
Mexico
Prior art keywords
preparation
amino
dimethyladamantane hydrochloride
hydrochloride
dimethyladamantane
Prior art date
Application number
MX2007007302A
Other languages
English (en)
Inventor
Valeriano Merli
Paola Daverio
Silvia Mantovani
Stefano Bianchi
Alessandro Spreafico
Original Assignee
Teva Pharm Fine Chemicals Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharm Fine Chemicals Srl filed Critical Teva Pharm Fine Chemicals Srl
Publication of MX2007007302A publication Critical patent/MX2007007302A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/38—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proporciona un proceso para la preparacion de clorhidrato de memantina, intermedios de el y su forma de sal de acido clorhidrico.
MX2007007302A 2005-01-11 2006-01-11 Proceso para la preparacion de clorhidrato de 1-amino-3,5-dimetiladamantano. MX2007007302A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64295705P 2005-01-11 2005-01-11
US67759905P 2005-05-03 2005-05-03
PCT/US2006/001204 WO2006076562A1 (en) 2005-01-11 2006-01-11 Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride

Publications (1)

Publication Number Publication Date
MX2007007302A true MX2007007302A (es) 2008-02-11

Family

ID=36282949

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2007007301A MX2007007301A (es) 2005-01-11 2006-01-11 Polimorfos de clorhidrato de memantina.
MX2007007302A MX2007007302A (es) 2005-01-11 2006-01-11 Proceso para la preparacion de clorhidrato de 1-amino-3,5-dimetiladamantano.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2007007301A MX2007007301A (es) 2005-01-11 2006-01-11 Polimorfos de clorhidrato de memantina.

Country Status (12)

Country Link
US (2) US7462743B2 (es)
EP (2) EP1836154A1 (es)
AT (1) ATE444950T1 (es)
CA (2) CA2591666A1 (es)
DE (1) DE602006009619D1 (es)
ES (1) ES2334579T3 (es)
HR (1) HRP20090676T1 (es)
IL (2) IL183244A0 (es)
MX (2) MX2007007301A (es)
PT (1) PT1836157E (es)
SI (1) SI1836157T1 (es)
WO (2) WO2006076562A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20050833A1 (it) 2005-05-10 2006-11-11 A M S A S P A Anonima Materie Sintetiche Affini Nuovo procedimento per la sintesi di aminoadamantani
WO2007132476A2 (en) * 2006-05-15 2007-11-22 Matrix Laboratories Limited A process for the preparation of memantine hydrochloride
WO2008005036A1 (en) * 2006-07-05 2008-01-10 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions of memantine
CN101038280B (zh) * 2007-04-11 2010-09-15 山东省医药工业研究所 一种盐酸美金刚中有关物质的hplc-elsd测定方法
WO2009151498A2 (en) * 2008-03-28 2009-12-17 Forest Laboratories Holdings Limited Memantine formulations
EP2373612B1 (en) 2008-12-17 2013-04-17 Merz Pharma GmbH & Co. KGaA Method for producing memantine
EP2555616A4 (en) * 2010-04-08 2014-04-02 Hetero Research Foundation METHOD FOR PRODUCING MEMANTINE HYDROCHLORIDE
WO2012051333A1 (en) 2010-10-12 2012-04-19 The Johns Hopkins University Antitussive compositions comprising memantine
CN102875387A (zh) * 2012-10-23 2013-01-16 滨州泓瑞医药科技有限公司 一种盐酸金刚烷胺的制备工艺
EP2949643A4 (en) * 2013-01-23 2016-09-07 Mitsubishi Gas Chemical Co PROCESS FOR THE PRODUCTION OF MEMANTINE
RU2021125455A (ru) 2013-11-15 2021-10-05 Экебиа Терапьютикс, Инк. Твердые формы { [5-(3-хлорфенил)-3-гидроксипиридин-2-карбонил]амино} уксусной кислоты, их композиции и применения
MX2018008190A (es) 2015-12-30 2018-11-12 Corium Int Inc Sistemas y metodos para la administracion transdermica a largo plazo.
WO2017223402A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
US20180028461A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
KR102555208B1 (ko) 2016-07-27 2023-07-17 코리움, 엘엘씨 아민 약물의 나트륨 바이카보네이트 제자리 전환 구동된 경피성 전달
WO2018022818A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Memantine transdermal delivery systems
AU2018392686A1 (en) 2017-12-20 2020-07-09 Corium Pharma Solutions, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
JP2019156756A (ja) * 2018-03-13 2019-09-19 宇部興産株式会社 １−アミノ−３，５−ジメチルアダマンタン塩酸塩の結晶
FI3843702T3 (fi) 2019-05-31 2023-10-09 Tecnimede Sociedade Tecnico Medicinal Sa Memantiinin ja donepetsiilin välittömästi vapauttava vakioannoksinen yhdistelmä
CN111909041B (zh) * 2020-08-12 2023-06-16 山东罗欣药业集团恒欣药业有限公司 一种用于治疗神经功能疾病药物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3391142A (en) * 1966-02-09 1968-07-02 Lilly Co Eli Adamantyl secondary amines
ES413944A1 (es) * 1972-04-20 1976-06-01 Merz & Co Procedimiento para la preparacion de compuestos de adamen- tano trisustituidos en las posiciones 1,3,5.
EP0392059B1 (de) * 1989-04-14 1993-09-15 Merz & Co. GmbH & Co. Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie
US5614560A (en) 1991-04-04 1997-03-25 Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
CZ282398B6 (cs) 1994-04-13 1997-07-16 Lachema A. S. Způsob výroby 1-R1-3-R2-tricyklo(3,3,1,1,3,7)decyl-5-aminu
US5599998A (en) * 1994-10-24 1997-02-04 Iowa State University Research Foundation, Inc. Method for the synthesis of adamantane amines
GB9812413D0 (en) * 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
JP2002275142A (ja) 2001-03-14 2002-09-25 Daicel Chem Ind Ltd アミド化合物の製造法
CN1125033C (zh) 2001-08-29 2003-10-22 中国科学院广州化学研究所 美金刚胺盐酸盐的合成方法
CN1400205A (zh) 2002-08-30 2003-03-05 中国科学院广州化学研究所 美金刚胺盐酸盐的制备方法
CN1240668C (zh) * 2003-09-10 2006-02-08 上海医药工业研究院 一种新的盐酸美金刚制备方法
WO2005069742A2 (en) * 2003-12-10 2005-08-04 Sun Pharmaceutical Industries Limited Crystal form ii of memantine hydrochloride
WO2005062724A2 (en) 2003-12-31 2005-07-14 Sun Pharmaceutical Industries Limited Novel process for the preparation of aminoadamantane derivatives
WO2007132476A2 (en) 2006-05-15 2007-11-22 Matrix Laboratories Limited A process for the preparation of memantine hydrochloride

Also Published As

Publication number Publication date
ES2334579T3 (es) 2010-03-12
WO2006076560A1 (en) 2006-07-20
ATE444950T1 (de) 2009-10-15
US20060173215A1 (en) 2006-08-03
IL183237A0 (en) 2007-08-19
US7462743B2 (en) 2008-12-09
WO2006076562A1 (en) 2006-07-20
PT1836157E (pt) 2009-11-24
CA2591666A1 (en) 2006-07-20
MX2007007301A (es) 2008-02-11
EP1836157A1 (en) 2007-09-26
EP1836154A1 (en) 2007-09-26
SI1836157T1 (sl) 2009-12-31
CA2591487A1 (en) 2006-07-20
DE602006009619D1 (de) 2009-11-19
IL183244A0 (en) 2007-08-19
HRP20090676T1 (hr) 2010-01-31
US20060217573A1 (en) 2006-09-28
EP1836157B1 (en) 2009-10-07

Similar Documents

Publication Publication Date Title
MX2007007302A (es) Proceso para la preparacion de clorhidrato de 1-amino-3,5-dimetiladamantano.
IL185107A0 (en) Process for preparing cinacalcet hydrochloride
ZA200609543B (en) Process for the production of an influenza vaccine
UA97382C2 (ru) Таннат разагилина
TW200716512A (en) Processes for preparing cinacalcet hydrochloride crystal form I
UA100367C2 (uk) Спосіб одержання мемантину і його гідрохлориду
EP1908749A4 (en) PROCESS FOR PREPARING ISOCYANATE, ISOCYANATE MADE ACCORDING TO IT AND USE OF ISOCYANATE
IL187979A0 (en) Manufacturing process for tigecycline
WO2006099468A3 (en) Process for the purification of duloxetine hydrochloride
IL195527A (en) Reliable benzyl, a process for their production and use as anti-inflammatory agents, intermediates and processes for their preparation
IL175390A0 (en) Parocess for the preparation of telmisartan
WO2006127941A3 (en) Amorphous cinacalcet hydrochloride and preparation thereof
IL186220A0 (en) Processes for the preparation of atomoxetine hydrochloride
TW200619205A (en) A method for preparing irbesartan and intermediates thereof
EG25292A (en) Process for the production of anilines.
IL183287A0 (en) Process for the production of anilines
TW200640839A (en) Process for preparing Tolterodine tartrate
IL186593A0 (en) A process for the purification of 10-deacetylbaccatine iii from 10-deacetyl-2-debenzoyl-2-pentenoylbaccatine iii
SG158860A1 (en) Processes for the preparation of aminoethoxybenzyl alcohols
IL184836A0 (en) Processes for preparing sertraline
TW200640836A (en) Processes for preparing sertraline
WO2006027658A3 (en) Process for the preparation of sertraline hydrochloride form ii
SG126905A1 (en) Process for producing cycloalkanone oximes
TWI366559B (en) Process for the production of anilines
EP1932827A4 (en) UNSATURATED ALIPHATIC PRIMARY AMINE AND PROCESS FOR PRODUCTION THEREOF